vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $11.5M, roughly 1.6× TRANSACT TECHNOLOGIES INC). On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 11.9%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $589.0K). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 3.5%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
ELMD vs TACT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $11.5M |
| Net Profit | $2.8M | — |
| Gross Margin | 78.4% | 47.6% |
| Operating Margin | 19.2% | -10.1% |
| Net Margin | 14.6% | — |
| Revenue YoY | 16.3% | 11.9% |
| Net Profit YoY | 40.3% | — |
| EPS (diluted) | $0.32 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $11.5M | ||
| Q3 25 | $16.9M | $13.2M | ||
| Q2 25 | $17.4M | $13.8M | ||
| Q1 25 | $15.7M | $13.1M | ||
| Q4 24 | $16.3M | $10.2M | ||
| Q3 24 | $14.7M | $10.9M | ||
| Q2 24 | $14.8M | $11.6M | ||
| Q1 24 | $13.9M | $10.7M |
| Q4 25 | $2.8M | — | ||
| Q3 25 | $2.1M | $15.0K | ||
| Q2 25 | $2.2M | $-143.0K | ||
| Q1 25 | $1.9M | $19.0K | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $1.5M | $-551.0K | ||
| Q2 24 | $1.8M | $-319.0K | ||
| Q1 24 | $1.5M | $-1.0M |
| Q4 25 | 78.4% | 47.6% | ||
| Q3 25 | 78.1% | 49.8% | ||
| Q2 25 | 78.3% | 48.2% | ||
| Q1 25 | 78.0% | 48.7% | ||
| Q4 24 | 77.7% | 44.2% | ||
| Q3 24 | 78.3% | 48.1% | ||
| Q2 24 | 76.2% | 52.7% | ||
| Q1 24 | 74.8% | 52.6% |
| Q4 25 | 19.2% | -10.1% | ||
| Q3 25 | 15.8% | 0.1% | ||
| Q2 25 | 17.5% | -1.9% | ||
| Q1 25 | 13.6% | -0.1% | ||
| Q4 24 | 15.6% | -10.3% | ||
| Q3 24 | 13.2% | -7.7% | ||
| Q2 24 | 15.7% | -3.8% | ||
| Q1 24 | 13.3% | -12.2% |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 12.6% | 0.1% | ||
| Q2 25 | 12.7% | -1.0% | ||
| Q1 25 | 12.1% | 0.1% | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 10.0% | -5.1% | ||
| Q2 24 | 12.3% | -2.8% | ||
| Q1 24 | 10.8% | -9.7% |
| Q4 25 | $0.32 | $-0.11 | ||
| Q3 25 | $0.25 | $0.00 | ||
| Q2 25 | $0.26 | $-0.01 | ||
| Q1 25 | $0.21 | $0.00 | ||
| Q4 24 | $0.22 | $-0.80 | ||
| Q3 24 | $0.16 | $-0.06 | ||
| Q2 24 | $0.20 | $-0.03 | ||
| Q1 24 | $0.17 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $31.1M |
| Total Assets | $54.9M | $44.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $20.4M | ||
| Q3 25 | $14.1M | $20.0M | ||
| Q2 25 | $15.3M | $17.7M | ||
| Q1 25 | $15.2M | $14.2M | ||
| Q4 24 | $16.2M | $14.4M | ||
| Q3 24 | $13.9M | $11.3M | ||
| Q2 24 | $16.1M | $11.1M | ||
| Q1 24 | $11.7M | $10.6M |
| Q4 25 | $45.4M | $31.1M | ||
| Q3 25 | $44.7M | $31.8M | ||
| Q2 25 | $43.2M | $31.3M | ||
| Q1 25 | $43.9M | $30.9M | ||
| Q4 24 | $43.6M | $30.6M | ||
| Q3 24 | $41.5M | $38.4M | ||
| Q2 24 | $44.5M | $38.5M | ||
| Q1 24 | $42.5M | $38.6M |
| Q4 25 | $54.9M | $44.8M | ||
| Q3 25 | $53.6M | $45.0M | ||
| Q2 25 | $53.8M | $44.5M | ||
| Q1 25 | $52.5M | $44.2M | ||
| Q4 24 | $52.3M | $44.0M | ||
| Q3 24 | $48.9M | $50.5M | ||
| Q2 24 | $52.2M | $50.4M | ||
| Q1 24 | $48.9M | $51.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $609.0K |
| Free Cash FlowOCF − Capex | $2.4M | $589.0K |
| FCF MarginFCF / Revenue | 12.7% | 5.1% |
| Capex IntensityCapex / Revenue | 3.4% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $609.0K | ||
| Q3 25 | $169.0K | $3.6M | ||
| Q2 25 | $3.9M | $3.6M | ||
| Q1 25 | $2.1M | $-161.0K | ||
| Q4 24 | $3.2M | $2.4M | ||
| Q3 24 | $2.3M | $327.0K | ||
| Q2 24 | $4.5M | $636.0K | ||
| Q1 24 | $1.4M | $-1.5M |
| Q4 25 | $2.4M | $589.0K | ||
| Q3 25 | $-83.0K | $3.6M | ||
| Q2 25 | $3.7M | $3.6M | ||
| Q1 25 | $1.9M | $-171.0K | ||
| Q4 24 | $2.9M | $2.4M | ||
| Q3 24 | $2.3M | $259.0K | ||
| Q2 24 | $4.5M | $499.0K | ||
| Q1 24 | $1.3M | $-1.6M |
| Q4 25 | 12.7% | 5.1% | ||
| Q3 25 | -0.5% | 27.1% | ||
| Q2 25 | 21.4% | 25.9% | ||
| Q1 25 | 12.2% | -1.3% | ||
| Q4 24 | 18.0% | 23.2% | ||
| Q3 24 | 15.5% | 2.4% | ||
| Q2 24 | 30.1% | 4.3% | ||
| Q1 24 | 9.1% | -14.9% |
| Q4 25 | 3.4% | 0.2% | ||
| Q3 25 | 1.5% | 0.5% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.6% | 1.0% |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.08× | 242.00× | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | 1.10× | -8.47× | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.57× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
TACT
Segment breakdown not available.
